Cargando…

Decision tree-based classification as a support to diagnosis in the Alzheimer’s disease continuum using cerebrospinal fluid biomarkers: insights from automated analysis

OBJECTIVE: Cerebrospinal fluid (CSF) biomarkers add accuracy to the diagnostic workup of cognitive impairment by illustrating Alzheimer’s disease (AD) pathology. However, there are no universally accepted cutoff values for the interpretation of AD biomarkers. The aim of this study is to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Alana, Pais, Marcos, Loureiro, Júlia, Stella, Florindo, Radanovic, Márcia, Gattaz, Wagner, Forlenza, Orestes, Talib, Leda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375672/ https://www.ncbi.nlm.nih.gov/pubmed/35739065 http://dx.doi.org/10.47626/1516-4446-2021-2277

Ejemplares similares

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Increased CSF levels of total Tau in patients with subcortical cerebrovascular pathology and cognitive impairment
por: Radanovic, Márcia, et al.
Publicado: (2017)

Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges
por: Pais, Marcos, et al.
Publicado: (2020)

Electroconvulsive therapy for treating patients with agitation and related behavioral disorders due to dementia: a systematic review
por: Stella, Florindo, et al.
Publicado: (2023)

Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort
por: Radanovic, Márcia, et al.
Publicado: (2019)

Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment
por: Damiano, Rodolfo Furlan, et al.
Publicado: (2023)

Impact of SARS-CoV-2 pandemic on mental health in the elderly: perspective from a psychogeriatric clinic at a tertiary hospital in São Paulo, Brazil
por: Forlenza, Orestes V., et al.
Publicado: (2020)

Diagnosis and biomarkers of predementia in Alzheimer's disease
por: Forlenza, Orestes V, et al.
Publicado: (2010)

New treatment strategies for Alzheimer's disease: is there a hope?
por: Aprahamian, Ivan, et al.
Publicado: (2013)

Cognitive impairment: an (in)dependent risk factor for mortality in older men?
por: Loureiro, Júlia C., et al.
Publicado: (2020)

Discourse abilities in euthymic elderly patients with bipolar disorder: a preliminary study
por: Valeriano, Maria Gabriela, et al.
Publicado: (2023)

Long-Term Lithium Treatment Increases cPLA(2) and iPLA(2) Activity in Cultured Cortical and Hippocampal Neurons
por: De-Paula, Vanessa de Jesus, et al.
Publicado: (2015)

Mental Health Status of Psychogeriatric Patients During the 2019 New Coronavirus Disease (COVID-19) Pandemic and Effects on Caregiver Burden
por: Penteado, Camila T., et al.
Publicado: (2020)

Mood disorders in the elderly: prevalence, functional impact, and management challenges
por: Valiengo, Leandro da Costa Lane, et al.
Publicado: (2016)

Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review
por: de Oliveira, Alexandra Martini, et al.
Publicado: (2015)

Anti-amyloid agents for treating incipient Alzheimer’s disease: a new hope?
por: Loureiro, Julia C., et al.
Publicado: (2022)

Plasma Biomarkers of Alzheimer’s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice
por: Pais, Marcos V., et al.
Publicado: (2023)

Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder
por: Costa, Alana C., et al.
Publicado: (2023)

Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects
por: Tanno, Luciana, et al.
Publicado: (2014)

Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects
por: Tanno, Luciana, et al.
Publicado: (2014)

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
por: Wang, Jun, et al.
Publicado: (2020)

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
por: Gobom, Johan, et al.
Publicado: (2022)

Textual Inference Comprehension in Mild Cognitive Impairment: The Influence of Semantic Processing and Verbal Episodic Memory
por: Maziero, Maria Paula, et al.
Publicado: (2021)

Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
por: Izzo, Giselle, et al.
Publicado: (2013)

Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review
por: Stella, Florindo, et al.
Publicado: (2021)

Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum
por: Lu, Yuanyuan
Publicado: (2022)

Objective Physical Function in the Alzheimer’s Disease Continuum: Association with Cerebrospinal Fluid Biomarkers in the ALBION Study
por: Sampatakakis, Stefanos N., et al.
Publicado: (2023)

Antipsychotics preserve telomere length in peripheral blood mononuclear cells after acute oxidative stress injury
por: Polho, Gabriel B., et al.
Publicado: (2021)

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
por: Benedet, Andréa L., et al.
Publicado: (2021)

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
por: Goossens, Julie, et al.
Publicado: (2023)

Implementation of an Automated Cerebrospinal Fluid Drainage System for Early Mobilization in Neurosurgical Patients
por: Arts, Sebastian, et al.
Publicado: (2021)

Cerebrospinal Fluid
por: Bailey, Cleta Sue, et al.
Publicado: (1997)

Cerebrospinal Fluid
por: Vernau, William, et al.
Publicado: (2008)

The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects
por: Tanno, Luciana Kase, et al.
Publicado: (2015)

Correction: The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects
por: Tanno, Luciana Kase, et al.
Publicado: (2015)

Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers
por: Zebhauser, Paul Theo, et al.
Publicado: (2022)

Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum
por: Moody, Jason F., et al.
Publicado: (2022)

The cerebrospinal fluid in retinoblastoma.
por: Ifekwunigwe, A. E., et al.
Publicado: (1966)

THE CEREBROSPINAL FLUID IN SYPHILIS
por: Ellis, Arthur W. M., et al.
Publicado: (1913)

Cerebrospinal fluid rhinorrhea
por: Mohanty, Aaron
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_thcpiojqgm5v9hsf6d8712f2mj